Targeting Protein–Protein Interactions and Fragment-Based Drug Discovery

Principles of Fluorescence Spectroscopy

Lakowicz, J. R. (1999) · Springer eBooks · doi:10.1007/978-1-4757-3061-6 · Cited by 26,948 · see citing works

Principles of Fluorescence Spectroscopy

Lakowicz, J. R. (2006) · Springer eBooks · doi:10.1007/978-0-387-46312-4 · Cited by 19,375 · see citing works

Comparative Protein Modelling by Satisfaction of Spatial Restraints

Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977 · see citing works

Some Factors in the Interpretation of Protein Denaturation

Kauzmann, W. (1959) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60608-7 · Cited by 4,880 · see citing works

In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · see citing works

How many drug targets are there?

Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505 · see citing works

The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored

Szklarczyk, D., Franceschini, A., Kuhn, M., Simonovic, M., Roth, A. C., Mínguez, P., Doerks, T., Stark, M., Muller, J., Bork, P., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq973 · Cited by 3,469 · see citing works

The Hydrophobic Effect: Formation of Micelles and Biological Membranes

Tanford, C. (1991) · Medical Entomology and Zoology · Cited by 3,331 · see citing works

The Hydrophobic Effect: Formation of Micelles and Biological Membranes

Walker, C. H. (1981) · FEBS Letters · doi:10.1016/0014-5793(81)80071-3 · Cited by 2,712 · see citing works

Principles of protein-protein interactions

Jones, S., & Thornton, J. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.13 · Cited by 2,684 · see citing works

The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability

Niesen, F., Berglund, H., & Vedadi, M. (2007) · Nature Protocols · doi:10.1038/nprot.2007.321 · Cited by 2,420 · see citing works

Structure and Mechanism in Protein Science

Fersht, A. (2017) · WORLD SCIENTIFIC eBooks · doi:10.1142/10574 · Cited by 2,078 · see citing works

Discovering High-Affinity Ligands for Proteins: SAR by NMR

Shuker, S. B., Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1996) · Science · doi:10.1126/science.274.5292.1531 · Cited by 2,045 · see citing works

A Hot Spot of Binding Energy in a Hormone-Receptor Interface

Clackson, T., & Wells, J. A. (1995) · Science · doi:10.1126/science.7529940 · Cited by 1,987 · see citing works

The atomic structure of protein-protein recognition sites 1 1Edited by A. R. Fersht

Conte, L. L., Chothia, C., & Janin, J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2439 · Cited by 1,967 · see citing works

Reaching for high-hanging fruit in drug discovery at protein–protein interfaces

Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,963 · see citing works

A small molecule–kinase interaction map for clinical kinase inhibitors

Fabian, M. A., Biggs, W., Treiber, D. K., Atteridge, C. E., Azimioara, M. D., Benedetti, M. G., Carter, T. A., Ciceri, P., Edeen, P. T., Floyd, M. B., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1068 · Cited by 1,901 · see citing works

Ligand efficiency: a useful metric for lead selection

Hopkins, A. L., Groom, C. R., & Alex, A. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03069-7 · Cited by 1,895 · see citing works

Structure and Mechanism in Protein Science. A guide to Enzyme Catalysis and Protein Folding

Howland, J. L. (2001) · Biochemistry and Molecular Biology Education · Cited by 1,823 · see citing works

An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor

Zhang, X., Gureasko, J., Shen, K., Cole, P. A., & Kuriyan, J. (2006) · Cell · doi:10.1016/j.cell.2006.05.013 · Cited by 1,650 · see citing works

Structure of Bcl-x _L -Bak Peptide Complex: Recognition Between Regulators of Apoptosis

Sattler, M., Liang, H., Nettesheim, D., Meadows, R. P., Harlan, J. E., Eberstadt, M., Yoon, H. S., Shuker, S. B., Chang, B. S., Minn, A. J., et al. (1997) · Science · doi:10.1126/science.275.5302.983 · Cited by 1,476 · see citing works

A network of protein–protein interactions in yeast

Schwikowski, B., Uetz, P. H., & Fields, S. (2000) · Nature Biotechnology · doi:10.1038/82360 · Cited by 1,371 · see citing works

Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix

Walensky, L. D., Kung, A. L., Escher, I., Malia, T. J., Barbuto, S., Wright, R. D., Wagner, G., Verdine, G. L., & Korsmeyer, S. J. (2004) · Science · doi:10.1126/science.1099191 · Cited by 1,349 · see citing works

How Hofmeister ion interactions affect protein stability

Baldwin, R. L. (1996) · Biophysical Journal · doi:10.1016/s0006-3495(96)79404-3 · Cited by 1,122 · see citing works

Hydrogen bonding and biological specificity analysed by protein engineering

Fersht, A. R., Shi, J., Knill-Jones, J. W., Lowe, D. M., Wilkinson, A. J., Blow, D. M., Brick, P., Carter, P. M., Waye, M. M. Y., & Winter, G. P. (1985) · Nature · doi:10.1038/314235a0 · Cited by 1,056 · see citing works

NMR Spectroscopy Techniques for Screening and Identifying Ligand Binding to Protein Receptors

Meyer, B., & Peters, T. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200390233 · Cited by 1,042 · see citing works

MINT: the Molecular INTeraction database

Chatr‐aryamontri, A., Ceol, A. G. M., Montecchi‐Palazzi, L., Nardelli, G., Schneider, M. V., Castagnoli, L., & Cesareni, G. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl950 · Cited by 1,027 · see citing works

The productivity crisis in pharmaceutical R&D

Pammolli, F., Magazzini, L., & Riccaboni, M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3405 · Cited by 918 · see citing works

Hydrophobic bonding and accessible surface area in proteins

Chothia, C. (1974) · Nature · doi:10.1038/248338a0 · Cited by 897 · see citing works

Fragment-based lead discovery

Rees, D. C., Congreve, M., Murray, C. W., & Carr, R. A. E. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1467 · Cited by 797 · see citing works

Unraveling hot spots in binding interfaces: progress and challenges

DeLano, W. L. (2002) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00283-x · Cited by 767 · see citing works

Electrostatic aspects of protein–protein interactions

Sheinerman, F. B., Norel, R., & Honig, B. H. (2000) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(00)00065-8 · Cited by 763 · see citing works

Hot spots—A review of the protein–protein interface determinant amino‐acid residues

Moreira, I. S., Fernandes, P. A., & Ramos, M. J. (2007) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.21396 · Cited by 760 · see citing works

Fundamental Aspects of Protein−Protein Association Kinetics

Schreiber, G., Haran, G., & Zhou, H. (2009) · Chemical Reviews · doi:10.1021/cr800373w · Cited by 739 · see citing works

Subcellular localization of the yeast proteomePreprint

Kumar, A., Agarwal, S., Heyman, J. A., Matson, S., Heidtman, M. I., Piccirillo, S., Umansky, L., Drawid, A., Jansen, R., Liu, Y., et al. (2002) · Genes & Development · doi:10.1101/gad.970902 · Cited by 737 · see citing works

Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2−p53 Interaction

Ding, K., Lu, Y., Nikolovska-Coleska, Z., Wang, G., Qiu, S., Shangary, S., Gao, W., Qin, D., Stuckey, J., Krajewski, K., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051122a · Cited by 702 · see citing works

Allosteric binding sites on cell-surface receptors: novel targets for drug discovery

Christopoulos, A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd746 · Cited by 665 · see citing works

Structure-based design of potent non-peptide MDM2 inhibitors

Ding, K., Lu, Y., Nikolovska-Coleska, Z., Qiu, S., Ding, Y., Gao, W., Stuckey, J., Krajewski, K., Roller, P. P., Tomita, Y., et al. (2005) · Journal of the American Chemical Society · doi:10.1021/ja051147z · Cited by 657 · see citing works

Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex

Lepourcelet, M., Chen, Y.-N. P., France, D. S., Wang, H., Crews, P., Petersen, F., Bruseo, C. W., Wood, A. W., & Shivdasani, R. A. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00334-9 · Cited by 653 · see citing works

The IntAct molecular interaction database in 2010

Aranda, B., Achuthan, P., Alam-Faruque, Y., Armean, I., Bridge, A., Derow, C., Feuermann, M., Ghanbarian, A. T., Kerrien, S., Khadake, J., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp878 · Cited by 620 · see citing works

Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors

Gandhi, L., Camidge, D. R., Ribeiro de Oliveira, M., Bonomi, P., Gandara, D., Khaira, D., Hann, C. L., McKeegan, E. M., Litvinovich, E., Hemken, P. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.6208 · Cited by 603 · see citing works

WaterLOGSY as a method for primary NMR screening: Practical aspects and range of applicability

Dalvit, C., Fogliatto, G., Stewart, A., Veronesi, M., & Stockman, B. J. (2001) · Journal of Biomolecular NMR · doi:10.1023/a:1013302231549 · Cited by 570 · see citing works

Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors

Karlsson, R., & Fält, A. (1997) · Journal of Immunological Methods · doi:10.1016/s0022-1759(96)00195-0 · Cited by 565 · see citing works

Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL

Degterev, A., Lugovskoy, A. A., Cardone, M. H., Mulley, B., Wagner, G., Mitchison, T. J., & Yuan, J. (2001) · Nature Cell Biology · doi:10.1038/35055085 · Cited by 550 · see citing works

High-throughput crystallography for lead discovery in drug design

Blundell, T. L., Jhoti, H., & Abell, C. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd706 · Cited by 529 · see citing works

Druggability Indices for Protein Targets Derived from NMR-Based Screening Data

Hajduk, P. J., Huth, J. R., & Fesik, S. W. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049131r · Cited by 525 · see citing works

Transient Protein-Protein Interactions: Structural, Functional, and Network Properties

Perkins, J. R., Diboun, I., Dessailly, B. H., Lees, J. G., & Orengo, C. A. (2010) · Structure · doi:10.1016/j.str.2010.08.007 · Cited by 522 · see citing works

Hot Regions in Protein–Protein Interactions: The Organization and Contribution of Structurally Conserved Hot Spot Residues

Keskin, O., Ma, B., & Nussinov, R. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.10.077 · Cited by 519 · see citing works

MINT, the molecular interaction database: 2009 update

Ceol, A. G. M., Chatr‐aryamontri, A., Licata, L., Peluso, D., Briganti, L., Perfetto, L., Castagnoli, L., & Cesareni, G. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp983 · Cited by 507 · see citing works

Protein−Protein Interactions: Interface Structure, Binding Thermodynamics, and Mutational Analysis

Stites, W. E. (1997) · Chemical Reviews · doi:10.1021/cr960387h · Cited by 491 · see citing works

Hydrogen bonds and salt bridges across protein-protein interfaces

Xu, D., Tsai, C.-J., & Nussinov, R. (1997) · Protein Engineering Design and Selection · doi:10.1093/protein/10.9.999 · Cited by 457 · see citing works

Binding in the growth hormone receptor complex.

Wells, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.1 · Cited by 439 · see citing works

Ligand configurational entropy and protein binding

Chang, C. A., Chen, W., & Gilson, M. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610494104 · Cited by 439 · see citing works

Studies of protein‐protein interfaces: A statistical analysis of the hydrophobic effect

Tsai, C., Lin, S. L., Wolfson, H. J., & Nussinov, R. (1997) · Protein Science · doi:10.1002/pro.5560060106 · Cited by 428 · see citing works

Fragment-Based Lead Discovery Using X-ray Crystallography

Hartshorn, M. J., Murray, C. W., Cleasby, A., Frederickson, M., Tickle, I. J., & Jhoti, H. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0495778 · Cited by 425 · see citing works

ASEdb: a database of alanine mutations and their effects on the free energy of binding in protein interactions

Thorn, K. S., & Bogan, A. A. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.3.284 · Cited by 403 · see citing works

Deciphering Protein–Protein Interactions. Part I. Experimental Techniques and Databases

Shoemaker, B. A., & Panchenko, A. R. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030042 · Cited by 394 · see citing works

Tethering: Fragment-Based Drug Discovery

Erlanson, D. A., Wells, J. A., & Braisted, A. C. (2004) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.33.110502.140409 · Cited by 385 · see citing works

Binding of small molecules to an adaptive protein–protein interface

Arkin, M. R., Randal, M., DeLano, W. L., Hyde, J., Luong, T. N., Oslob, J. D., Raphael, D. R., Taylor, L., Wang, J., McDowell, R. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252756299 · Cited by 376 · see citing works

Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo

Böttger, A., Böttger, V., Sparks, A., Liu, W.-L., Howard, S. F., & Lane, D. P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00374-5 · Cited by 363 · see citing works

Protein-protein recognition: Crystal structural analysis of a barnase-barstar complex at 2.0-.ANG. resolution

Buckle, A. M., Schreiber, G., & Fersht, A. R. (1994) · Biochemistry · doi:10.1021/bi00196a004 · Cited by 359 · see citing works

Keynote review: Structural biology and drug discovery

Congreve, M., Murray, C. W., & Blundell, T. L. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03484-7 · Cited by 338 · see citing works

The Thermodynamics of Protein–Ligand Interaction and Solvation: Insights for Ligand Design

Olsson, T. S. G., Williams, M. A., Pitt, W. R., & Ladbury, J. E. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.09.073 · Cited by 335 · see citing works

Structure-based drug design: progress, results and challenges

Verlinde, C. L. M. J., & Hol, W. G. J. (1994) · Structure · doi:10.1016/s0969-2126(00)00060-5 · Cited by 331 · see citing works

The price of lost freedom: entropy of bimolecular complex formation

Finkelstein, A. V., & Janin, J. (1989) · Protein Engineering Design and Selection · doi:10.1093/protein/3.1.1 · Cited by 329 · see citing works

Deciphering Protein–Protein Interactions. Part II. Computational Methods to Predict Protein and Domain Interaction Partners

Shoemaker, B. A., & Panchenko, A. R. (2007) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0030043 · Cited by 325 · see citing works

Discovering novel ligands for macromolecules using X-ray crystallographic screening

Nienaber, V. L., Richardson, P. L., Klighofer, V., Bouska, J. J., Giranda, V. L., & Greer, J. (2000) · Nature Biotechnology · doi:10.1038/80319 · Cited by 322 · see citing works

Toward Proteomimetics: Terphenyl Derivatives as Structural and Functional Mimics of Extended Regions of an α-Helix

Orner, B. P., Ernst, J. T., & Hamilton, A. D. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0025548 · Cited by 320 · see citing works

Integrated network analysis platform for protein-protein interactions

Wu, J., Vallenius, T., Ovaska, K., Westermarck, J. K., Mäkelä, T. P., & Hautaniemi, S. (2008) · Nature Methods · doi:10.1038/nmeth.1282 · Cited by 320 · see citing works

Tissue specificity and the human protein interaction network

Bossi, A., & Lehner, B. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.17 · Cited by 319 · see citing works

Discovery of Potent Nonpeptide Inhibitors of Stromelysin Using SAR by NMR

Hajduk, P. J., Sheppard, G. S., Nettesheim, D. G., Olejniczak, E. T., Shuker, S. B., Meadows, R. P., Steinman, D. H., Carrera, G. M., Marcotte, P. A., Severin, J. M., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja9702778 · Cited by 318 · see citing works

Literature-curated protein interaction datasets

Cusick, M. E., Yu, H., Smolyar, A., Venkatesan, K., Carvunis, A., Simonis, N., Rual, J.-F. M., Borick, H., Falter‐Braun, P., Dreze, M., et al. (2008) · Nature Methods · doi:10.1038/nmeth.1284 · Cited by 307 · see citing works

Discovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-x L from NMR and Parallel Synthesis

Petros, A. M., Dinges, J., Augeri, D. J., Baumeister, S. A., Betebenner, D. A., Bures, M. G., Elmore, S. W., Hajduk, P. J., Joseph, M. K., Landis, S. K., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0507532 · Cited by 295 · see citing works

Predicting protein druggability

Hajduk, P. J., Huth, J. R., & Tse, C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03624-x · Cited by 289 · see citing works

A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor.

Bass, S., Mulkerrin, M. G., & Wells, J. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4498 · Cited by 285 · see citing works

Apoptosis-based therapies and drug targets

Fischer, U., & Schulze‐Osthoff, K. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401556 · Cited by 280 · see citing works

Interaction of barnase with its polypeptide inhibitor barstar studied by protein engineering

Schreiber, G., & Fersht, A. R. (1993) · Biochemistry · doi:10.1021/bi00070a025 · Cited by 280 · see citing works

Direct comparison of binding equilibrium, thermodynamic, and rate constants determined by surface‐ and solution‐based biophysical methods

Day, Y. S. N., Baird, C. L., Rich, R. L., & Myszka, D. G. (2002) · Protein Science · doi:10.1110/ps.4330102 · Cited by 273 · see citing works

Protein–protein interaction at crystal contacts

Janin, J., & Rodier, F. (1995) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340230413 · Cited by 269 · see citing works

Introduction to Fragment-Based Drug Discovery

Erlanson, D. A. (2011) · Topics in current chemistry · doi:10.1007/128_2011_180 · Cited by 269 · see citing works

Discovery of a Potent Small Molecule IL-2 Inhibitor through Fragment Assembly

Braisted, A. C., Oslob, J. D., DeLano, W. L., Hyde, J., McDowell, R. S., Waal, N. D., Yu, C. H., Arkin, M. R., & Raimundo, B. C. (2003) · Journal of the American Chemical Society · doi:10.1021/ja034247i · Cited by 256 · see citing works

Electrostatic complementarity at protein/protein interfaces 1 1Edited by B. Honig

McCoy, A. J., Epa, V. C., & Colman, P. M. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.0987 · Cited by 249 · see citing works

Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal.

Ladbury, J. E., Lemmon, M. A., Zhou, M., Green, J., Botfield, M. C., & Schlessinger, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3199 · Cited by 249 · see citing works

Crystal Structure of ARF1•Sec7 Complexed with Brefeldin A and Its Implications for the Guanine Nucleotide Exchange Mechanism

Mossessova, E., Corpina, R. A., & Goldberg, J. D. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00475-1 · Cited by 242 · see citing works

Human Gene Coexpression Landscape: Confident Network Derived from Tissue Transcriptomic Profiles

Prieto, C. A. V., Risueño, A., Fontanillo, C., & Rivas, J. D. L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003911 · Cited by 239 · see citing works

Consolidating the set of known human protein-protein interactions in preparation for large-scale mapping of the human interactome

Ramani, A. K., Bunescu, R., Mooney, R. J., & Marcotte, E. M. (2005) · Genome biology · doi:10.1186/gb-2005-6-5-r40 · Cited by 239 · see citing works

Protein binding versus protein folding: the role of hydrophilic bridges in protein associations 1 1Edited by B. Honig

Xu, D., Lin, S. L., & Nussinov, R. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0712 · Cited by 231 · see citing works

NMR-based screening in drug discovery

Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1999) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500003528 · Cited by 229 · see citing works

Morphology of protein–protein interfaces

Larsen, T. A., Olson, A. J., & Goodsell, D. S. (1998) · Structure · doi:10.1016/s0969-2126(98)00044-6 · Cited by 228 · see citing works

Wet and dry interfaces: the role of solvent in protein–protein and protein–DNA recognition

Janin, J. (1999) · Structure · doi:10.1016/s0969-2126(00)88333-1 · Cited by 224 · see citing works

Protein–Protein Interactions: Hot Spots and Structurally Conserved Residues often Locate in Complemented Pockets that Pre-organized in the Unbound States: Implications for Docking

Li, X., Keskin, Ö., Ma, B., Nussinov, R., & Liang, J. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.09.051 · Cited by 216 · see citing works

An automated microseed matrix-screening method for protein crystallization

D'Arcy, A., Villard, F., & Marsh, M. (2007) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444907007652 · Cited by 214 · see citing works

Free Energy, Entropy, and Induced Fit in Host−Guest Recognition: Calculations with the Second-Generation Mining Minima Algorithm

Chang, C. A., & Gilson, M. K. (2004) · Journal of the American Chemical Society · doi:10.1021/ja047115d · Cited by 212 · see citing works

Structural biology in fragment-based drug design

Murray, C. W., & Blundell, T. L. (2010) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2010.04.003 · Cited by 208 · see citing works

Specific versus non-specific contacts in protein crystals

Janin, J. (1997) · Nature Structural Biology · doi:10.1038/nsb1297-973 · Cited by 206 · see citing works

An analysis of conformational changes on protein–protein association: implications for predictive docking

Betts, M. J., & Sternberg, M. J. E. (1999) · Protein Engineering Design and Selection · doi:10.1093/protein/12.4.271 · Cited by 206 · see citing works

Temperature, stability, and the hydrophobic interaction

Schellman, J. A. (1997) · Biophysical Journal · doi:10.1016/s0006-3495(97)78324-3 · Cited by 204 · see citing works

In situ assembly of enzyme inhibitors using extended tethering

Erlanson, D. A., Lam, J. W., Wiesmann, C., Luong, T. N., Simmons, R. L., DeLano, W. L., Choong, I., Burdett, M. T., Flanagan, W. M., Lee, D. M., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt786 · Cited by 204 · see citing works

The consequences of translational and rotational entropy lost by small molecules on binding to proteins

Murray, C. W., & Verdonk, M. L. (2002) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1022446720849 · Cited by 201 · see citing works

Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry

McMillan, K., Adler, M., Auld, D. S., Baldwin, J. J., Blasko, E., Browne, L. J., Chelsky, D., Davey, D. D., Dolle, R. E., Eagen, K. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1506 · Cited by 200 · see citing works

Electrostatic enhancement of diffusion-controlled protein-protein association: comparison of theory and experiment on barnase and barstar 1 1Edited by B. Honig

Vijayakumar, M., Wong, K.-Y., Schreiber, G., Fersht, A. R., Szabó, A., & Zhou, H. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1747 · Cited by 199 · see citing works

Short constrained peptides that inhibit HIV-1 entry

Sia, S. K., Carr, P. A., Cochran, A. G., Malashkevich, V. N., & Kim, P. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232566599 · Cited by 195 · see citing works

Free Energy Landscapes of Encounter Complexes in Protein-Protein Association

Camacho, C. J., Weng, Z., Vajda, S., & DeLisi, C. (1999) · Biophysical Journal · doi:10.1016/s0006-3495(99)77281-4 · Cited by 194 · see citing works

Protein—protein crystal‐packing contacts

Carugo, O., & Argos, P. (1997) · Protein Science · doi:10.1002/pro.5560061021 · Cited by 193 · see citing works

Targeting Protein-Protein Interactions with Small Molecules: Challenges and Perspectives for omputational Binding Epitope Detection and Ligand Finding

González-Ruiz, D., & Gohlke, H. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706778201530 · Cited by 190 · see citing works

Surface Plasmon Resonance Based Assay for the Detection and Characterization of Promiscuous Inhibitors

Giannetti, A. M., Koch, B., & Browner, M. F. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm700952v · Cited by 188 · see citing works

Bioactivation and Hepatotoxicity of Nitroaromatic Drugs

Boelsterli, U. A., Ho, H. K., Zhou, S.-F., & Leow, K. Y. (2006) · Current Drug Metabolism · doi:10.2174/138920006778520606 · Cited by 186 · see citing works

Inhibition of protein–protein interactions: The discovery of druglike β‐catenin inhibitors by combining virtual and biophysical screening

Trosset, J., Dalvit, C., Knapp, S., Fasolini, M., Veronesi, M., Mantegani, S., Gianellini, L. M., Catana, C., Sundström, M., Stouten, P. F. W., et al. (2006) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20955 · Cited by 182 · see citing works

Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery

Blundell, T. L., Sibanda, B. L., Montalvão, R. W., Brewerton, S. C., Chelliah, V., Worth, C. L., Harmer, N. J., Davies, O. R., & Burke, D. F. (2006) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2005.1800 · Cited by 178 · see citing works

(α/β+α)-Peptide Antagonists of BH3 Domain/Bcl-xL Recognition: Toward General Strategies for Foldamer-Based Inhibition of Protein−Protein Interactions

Sadowsky, J., Fairlie, W. D., Hadley, E. B., Lee, H., Umezawa, N., Nikolovska‐Coleska, Z., Wang, S., Huang, D. C. S., Tomita, Y. A., & Gellman, S. H. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0662523 · Cited by 175 · see citing works

Inhibiting HIV Fusion with a β-Peptide Foldamer

Stephens, O. M., Kim, S., Welch, B. D., Hodsdon, M. E., Kay, M. S., & Schepartz, A. (2005) · Journal of the American Chemical Society · doi:10.1021/ja053444+ · Cited by 174 · see citing works

Step-wise Mutation of Barnase to Binase

Serrano, L. G., Day, A. G., & Fersht, A. R. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1508 · Cited by 173 · see citing works

Surface electrostatic interactions contribute little to stability of barnase

Sali, D. S., Bycroft, M., & Fersht, A. R. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90117-o · Cited by 172 · see citing works

Between a rock and a hard place?

Whitty, A., & Kumaravel, G. (2006) · Nature Chemical Biology · doi:10.1038/nchembio0306-112 · Cited by 170 · see citing works

Protein-protein interaction databases: keeping up with growing interactomes

Lehne, B. C., & Schlitt, T. (2009) · Human Genomics · doi:10.1186/1479-7364-3-3-291 · Cited by 168 · see citing works

Crystallization of protein–ligand complexes

Hassell, A. M., An, G., Bledsoe, R. K., Bynum, J. M., Carter, H. L., Deng, S.-J., Gampe, R. T., Grisard, T. E., Madauss, K. P., Nolte, R. T., et al. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906047020 · Cited by 165 · see citing works

Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo

Koblish, H. K., Zhao, S., Franks, C. F., Donatelli, R. R., Tominovich, R. M., LaFrance, L. V., Leonard, K. A., Gushue, J. M., Parks, D. J., Calvo, R. R., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0199 · Cited by 164 · see citing works

Contribution of Surface Salt Bridges to Protein Stability,

Strop, P., & Mayo, S. L. (2000) · Biochemistry · doi:10.1021/bi992257j · Cited by 159 · see citing works

Enhanced Metabolic Stability and Protein‐Binding Properties of Artificial α Helices Derived from a Hydrogen‐Bond Surrogate: Application to Bcl‐xL

Wang, D., Liao, W., & Arora, P. S. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200501603 · Cited by 156 · see citing works

Atomic Interactions and Profile of Small Molecules Disrupting Protein–Protein Interfaces: the TIMBAL Database

Higueruelo, A. P., Schreyer, A. M., Bickerton, G. R., Pitt, W. R., Groom, C. R., & Blundell, T. L. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00889.x · Cited by 155 · see citing works

A Novel Small-Molecule Inhibitor of Protein Kinase Cι Blocks Transformed Growth of Non–Small-Cell Lung Cancer Cells

Stallings‐Mann, M. L., Jamieson, L., Regala, R. P., Weems, C. R., Murray, N. R., & Fields, A. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3405 · Cited by 154 · see citing works

On the number of protein-protein interactions in the yeast proteome

Grigoriev, A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg466 · Cited by 150 · see citing works

Selective Inhibition of c-Myc/Max Dimerization and DNA Binding by Small Molecules

Kiessling, A., Sperl, B., Hollis, A., Eick, D., & Berg, T. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.05.011 · Cited by 148 · see citing works

A Mutational Analysis of Binding Interactions in an Antigen−Antibody Protein−Protein Complex

Dall’Acqua, W. F., Goldman, E. R., Lin, W., Teng, C., Tsuchiya, D., Li, H., Ysern, X., Braden, B. C., Li, Y., Smith‐Gill, S. J., et al. (1998) · Biochemistry · doi:10.1021/bi980148j · Cited by 147 · see citing works

Design of GFB-111, a platelet-derived growth factor binding molecule with antiangiogenic and anticancer activity against human tumors in mice

Blaskovich, M. A., Lin, Q., Delarue, F. L., Sun, J., Park, H. S., Coppola, D., Hamilton, A. D., & Sebti, S. M. (2000) · Nature Biotechnology · doi:10.1038/80257 · Cited by 143 · see citing works

Hot-spot mimicry of a cytokine receptor by a small molecule

Thanos, C. D., DeLano, W. L., & Wells, J. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607058103 · Cited by 141 · see citing works

Physical and Functional Interaction between Wild-Type p53 and mdm2 Proteins

Haines, D. S., Landers, J. E., Engle, L. J., & George, D. L. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1171 · Cited by 136 · see citing works

Application of Fragment Screening and Fragment Linking to the Discovery of Novel Thrombin Inhibitors

Howard, N., Abell, C., Blakemore, W. E., Chessari, G., Congreve, M., Howard, S., Jhoti, H., Murray, C. W., Seavers, L. C. A., & van Montfort, R. L. M. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050850v · Cited by 134 · see citing works

Small‐molecule protein–protein interaction inhibitors: Therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations

Buchwald, P. (2010) · IUBMB Life · doi:10.1002/iub.383 · Cited by 133 · see citing works

Identification of a Small Molecule Inhibitor of the IL-2/IL-2Rα Receptor Interaction Which Binds to IL-2

Tilley, J., Chen, L., Fry, D. C., Emerson, S. D., Powers, G. D., Biondi, D. A., Varnell, T. A., Trilles, R. V., Guthrie, R. W., Mennona, F. A., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja970702x · Cited by 129 · see citing works

Structure–Activity Studies in a Family of β‐Hairpin Protein Epitope Mimetic Inhibitors of the p53–HDM2 Protein–Protein Interaction

Fasan, R., Dias, R. L. A., Moehle, K., Zerbe, O., Obrecht, D., Mittl, P. R. E., Grütter, M. G., & Robinson, J. A. (2006) · ChemBioChem · doi:10.1002/cbic.200500452 · Cited by 129 · see citing works

Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery

Jahnke, W., Rondeau, J., Cotesta, S., Marzinzik, A. L., Pellé, X., Geiser, M., Strauss, A., Götte, M., Bitsch, F., Hemmig, R., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.421 · Cited by 129 · see citing works

Protein Prosthesis: A Semisynthetic Enzyme with a β-Peptide Reverse Turn

Arnold, U., Hinderaker, M. P., Nilsson, B. L., Huck, B. R., Gellman, S. H., & Raines, R. T. (2002) · Journal of the American Chemical Society · doi:10.1021/ja026114n · Cited by 125 · see citing works

Small Molecule Inhibitors of Protein–Protein Interactions

Roberts, G. C. K. (2012) · Springer eBooks · doi:10.1007/978-3-642-16712-6_100964 · Cited by 118 · see citing works

Protein-Protein Interfaces: Architectures and Interactions in Protein-Protein Interfaces and in Protein Cores. Their Similarities and Differences

Tsai, C., Lin, S. L., Wolfson, H. J., & Nussinov, R. (1996) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239609106582 · Cited by 117 · see citing works

A Novel Approach for Characterizing Protein Ligand Complexes: Molecular Basis for Specificity of Small-Molecule Bcl-2 Inhibitors

Lugovskoy, A. A., Degterev, A., Fahmy, A. F., Zhou, P., Gross, J. D., Yuan, J., & Wagner, G. (2002) · Journal of the American Chemical Society · doi:10.1021/ja011239y · Cited by 116 · see citing works

Macromolecular recognition in the Protein Data Bank

Janin, J., Rodier, F., Chakrabarti, P., & Bahadur, R. P. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s090744490603575x · Cited by 114 · see citing works

Structure-based screening of low-affinity compounds

Carr, R. A. E., & Jhoti, H. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02245-6 · Cited by 110 · see citing works

Cross-Linking Strategy for Molecular Recognition and Fluorescent Sensing of a Multi-phosphorylated Peptide in Aqueous Solution

Ojida, A., Inoue, M.-A., Mito-oka, Y., & Hamachi, I. (2003) · Journal of the American Chemical Society · doi:10.1021/ja036317r · Cited by 109 · see citing works

Protein–protein interactions in the allosteric regulation of protein kinases

Pellicena, P., & Kuriyan, J. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.10.007 · Cited by 106 · see citing works

Identification of Potent and Selective Small-Molecule Inhibitors of Caspase-3 through the Use of Extended Tethering and Structure-Based Drug Design

Choong, I., Lew, W., Lee, D. M., Pham, P., Burdett, M. T., Lam, J. W., Wiesmann, C., Luong, T. N., Fahr, B. J., DeLano, W. L., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020230j · Cited by 106 · see citing works

In vitro display technologies reveal novel biopharmaceutics

Rothe, A., Hosse, R. J., & Power, A. B. E. (2006) · The FASEB Journal · doi:10.1096/fj.05-5650rev · Cited by 105 · see citing works

Fragment-Based Screening Using Surface Plasmon Resonance Technology

Perspicace, S., Banner, D. W., Benz, J., Müller, F., Schlatter, D., & Huber, W. (2009) · SLAS DISCOVERY · doi:10.1177/1087057109332595 · Cited by 105 · see citing works

Structure-based discovery of an inhibitor of Arf activation by Sec7 domains through targeting of protein–protein complexes

Viaud, J., Zeghouf, M., Barelli, H., Zeeh, J., Padilla, A., Guibert, B., Chardin, P., Royer, C. A., Cherfils, J., & Chavanieu, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700773104 · Cited by 98 · see citing works

Higher throughput calorimetry: opportunities, approaches and challenges

Torres, F. E., Recht, M. I., Coyle, J. E., Bruce, R. H., & Williams, G. (2010) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2010.09.001 · Cited by 98 · see citing works

Hydrophobic patches on protein subunit interfaces: characteristics and prediction.

Lijnzaad, P., & Argos, P. (1997) · PubMed · Cited by 96 · see citing works

Discovery of novel inhibitors of the ZipA/FtsZ complex by NMR fragment screening coupled with structure-based design

Tsao, D. H. H., Sutherland, A. G., Jennings, L. D., Li, Y., Rush, T. S., Alvarez, J. C., Ding, W., Dushin, E. G., Dushin, R. G., Haney, S. A., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.07.050 · Cited by 93 · see citing works

Prevention of MKK6-Dependent Activation by Binding to p38α MAP Kinase

Sullivan, J. E., Holdgate, G. A., Campbell, D., Timms, D. A., Gerhardt, S., Breed, J., Breeze, A. L., Bermingham, A., Pauptit, R. A., Norman, R. A., et al. (2005) · Biochemistry · doi:10.1021/bi051714v · Cited by 90 · see citing works

Contribution of Cation−π Interactions to Protein Stability

Prajapati, R. S., Sirajuddin, M., Durani, V., Sreeramulu, S., & Varadarajan, R. (2006) · Biochemistry · doi:10.1021/bi061275f · Cited by 87 · see citing works

Drugging challenging targets using fragment-based approaches

Coyne, A. G., Scott, D. E., & Abell, C. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.02.010 · Cited by 86 · see citing works

Effects of Core Mutations on the Folding of a β-Sheet Protein: Implications for Backbone Organization in the I-State

Lorch, M., Mason, J. M., Clarke, A. R., & Parker, M. J. (1999) · Biochemistry · doi:10.1021/bi9817820 · Cited by 86 · see citing works

Monitoring the Effects of Antagonists on Protein−Protein Interactions with NMR Spectroscopy

D’Silva, L., Ozdowy, P., Krajewski, M., Rothweiler, U., Singh, M., & Holak, T. A. (2005) · Journal of the American Chemical Society · doi:10.1021/ja052143x · Cited by 86 · see citing works

Integrating Fragment Assembly and Biophysical Methods in the Chemical Advancement of Small-Molecule Antagonists of IL-2: An Approach for Inhibiting Protein−Protein Interactions

Raimundo, B. C., Oslob, J. D., Braisted, A. C., Hyde, J., McDowell, R. S., Randal, M., Waal, N. D., Wilkinson, J., Yu, C. H., & Arkin, M. R. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049967u · Cited by 86 · see citing works

Highly Discriminating Protein–Protein Interaction Specificities in the Context of a Conserved Binding Energy Hotspot

Li, W., Keeble, A. H., Giffard, C. J., James, R., Moore, G. R., & Kleanthous, C. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.005 · Cited by 86 · see citing works

The SeeDs Approach: Integrating Fragments into Drug Discovery

Hubbard, R. E., Davis, B. J., Chen, I., & Drysdale, M. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607782341109 · Cited by 86 · see citing works

Hydrophobic patches on protein subunit interfaces: Characteristics and prediction

Lijnzaad, P., & Argos, P. (1997) · Proteins Structure Function and Bioinformatics · doi:10.1002/(sici)1097-0134(199707)28:3 · Cited by 86 · see citing works

Fragment Screening Using X-Ray Crystallography

Davies, T. G., & Tickle, I. J. (2011) · Topics in current chemistry · doi:10.1007/128_2011_179 · Cited by 82 · see citing works

Fragment Growing Induces Conformational Changes in Acetylcholine-Binding Protein: A Structural and Thermodynamic Analysis

Edink, E., Rucktooa, P., Retra, K., Akdemir, A., Nahar, T. T., Zuiderveld, O. P., van Elk, R., Janssen, E., van Nierop, P., van Muijlwijk‐Koezen, J. E., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja110571r · Cited by 80 · see citing works

Dissecting the energetics of an antibody‐antigen interface by alanine shaving and molecular grafting

Jin, L., & Wells, J. A. (1994) · Protein Science · doi:10.1002/pro.5560031219 · Cited by 79 · see citing works

APID2NET: unified interactome graphic analyzer

Hernández-Toro, J., Prieto, C. A. V., & Rivas, J. D. L. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm373 · Cited by 78 · see citing works

Contribution of long-range electrostatic interactions to the stabilization of the catalytic transition state of the serine protease subtilisin BPN'

Jackson, S., & Fersht, A. R. (1993) · Biochemistry · doi:10.1021/bi00213a021 · Cited by 77 · see citing works

Structural and thermodynamic analysis of the packing of two α-helices in bacteriophage T4 lysozyme

Daopin, S., Alber, T., Baase, W. A., Wozniak, J. A., & Matthews, B. W. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)80079-a · Cited by 77 · see citing works

Minimized proteins

Cunningham, B. C., & Wells, J. A. (1997) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(97)80107-8 · Cited by 77 · see citing works

Drug-Like Inhibitors of Protein-Protein Interactions: A Structural Examination of Effective Protein Mimicry

Fry, D. C. (2008) · Current Protein and Peptide Science · doi:10.2174/138920308784533989 · Cited by 76 · see citing works

Structure-based drug design

Colman, P. M. (1994) · Current Opinion in Structural Biology · doi:10.1016/0959-440x(94)90268-2 · Cited by 75 · see citing works

Surface Salt Bridges, Double-Mutant Cycles, and Protein Stability: an Experimental and Computational Analysis of the Interaction of the Asp 23 Side Chain with the N-Terminus of the N-Terminal Domain of the Ribosomal Protein L9

Luisi, D. L., Snow, C. D., Lin, J.-J., Hendsch, Z. S., Tidor, B., & Raleigh, D. P. (2003) · Biochemistry · doi:10.1021/bi027202n · Cited by 74 · see citing works

Identification of a direct interaction between interleukin 2 and the p64 interleukin 2 receptor gamma chain.

Voss, S. D., Leary, T. P., Sondel, P. M., & Robb, R. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2428 · Cited by 73 · see citing works

Selective disruption of protein aggregation by cyclodextrin dimers

Leung, D. K.-W., Yang, Z., & Breslow, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5050 · Cited by 72 · see citing works

Structural response to mutation at a protein-protein interface 1 1Edited by R. Huber

Vaughan, C. K., Buckle, A. M., & Fersht, A. R. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2559 · Cited by 72 · see citing works

Inhibition of Human Papillomavirus DNA Replication by Small Molecule Antagonists of the E1-E2 Protein Interaction

White, P. W., Titolo, S., Brault, K., Thauvette, L., Pelletier, A., Welchner, E., Bourgon, L., Doyon, L., Ogilvie, W. W., Yoakim, C., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303608200 · Cited by 71 · see citing works

β-Peptides with improved affinity for hDM2 and hDMX

Harker, E. A., Daniels, D. S., Guarracino, D. A., & Schepartz, A. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.01.039 · Cited by 71 · see citing works

α-Helix mimetics as inhibitors of protein–protein interactions

Saraogi, I., & Hamilton, A. D. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361414 · Cited by 70 · see citing works

From Crystal Packing to Molecular Recognition: Prediction and Discovery of a Binding Site on the Surface of Polo‐Like Kinase 1

Sledz, P., Stubbs, C. J., Lang, S., Yang, Y., McKenzie, G. J., Venkitaraman, A. R., Hyvönen, M., & Abell, C. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201008019 · Cited by 69 · see citing works

Surface Recognition and Fluorescence Sensing of Histone by Dansyl-Appended Cyclophane-Based Resorcinarene Trimer

Hayashida, O., Ogawa, N., & Uchiyama, M. (2007) · Journal of the American Chemical Society · doi:10.1021/ja074906h · Cited by 69 · see citing works

An Orally Bioavailable Pyrrolinone Inhibitor of HIV-1 Protease: Computational Analysis and X-ray Crystal Structure of the Enzyme Complex

Smith, A. B., Hirschmann, R. F., Pasternak, A., Yao, W., Sprengeler, P. A., Holloway, M. K., Kuo, L. C., Chen, Z., Darke, P. L., & Schleif, W. A. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970195u · Cited by 63 · see citing works

Combining NMR and X-ray Crystallography in Fragment-Based Drug Discovery: Discovery of Highly Potent and Selective BACE-1 Inhibitors

Wyss, D. F., Wang, Y., Eaton, H. L., Strickland, C., Voigt, J. H., Zhu, Z., & Stamford, A. W. (2011) · Topics in current chemistry · doi:10.1007/128_2011_183 · Cited by 56 · see citing works

Recurated protein interaction datasets

Salwiński, Ł., Licata, L., Winter, A. G., Thorneycroft, D., Khadake, J. R., Ceol, A. G. M., Chatr‐aryamontri, A., Oughtred, R., Livstone, M. S., Boucher, L., et al. (2009) · Nature Methods · doi:10.1038/nmeth1209-860 · Cited by 56 · see citing works

Identification of MMP-12 Inhibitors by Using Biosensor-Based Screening of a Fragment Library

Nordström, H., Gossas, T., Hämäläinen, M., Källblad, P., Nyström, S., Wallberg, H., & Danielson, U. H. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8000289 · Cited by 51 · see citing works

Characterization of the Minimal DNA Binding Domain of the Human Papillomavirus E1 Helicase: Fluorescence Anisotropy Studies and Characterization of a Dimerization-Defective Mutant Protein

Titolo, S., Brault, K., Majewski, J., White, P. W., & Archambault, J. (2003) · Journal of Virology · doi:10.1128/jvi.77.9.5178-5191.2003 · Cited by 51 · see citing works

NMR characterization of interleukin‐2 in complexes with the IL‐2Rα receptor component, and with low molecular weight compounds that inhibit the IL‐2/IL‐Rα interaction

Emerson, S. D., Palermo, R. E., Liu, C., Tilley, J., Chen, L., Danho, W., Madison, V., Greeley, D. N., Ju, G., & Fry, D. C. (2003) · Protein Science · doi:10.1110/ps.0232803 · Cited by 51 · see citing works

Combining Biophysical Screening and X-Ray Crystallography for Fragment-Based Drug Discovery

Hennig, M., Ruf, A., & Huber, W. (2011) · Topics in current chemistry · doi:10.1007/128_2011_225 · Cited by 48 · see citing works

Synthesis of a Negatively Charged Dibenzofuran-Based β-Turn Mimetic and Its Incorporation into the WW Miniprotein-Enhanced Solubility without a Loss of Thermodynamic Stability

Kaul, R. K., Deechongkit, S., & Kelly, J. W. (2002) · Journal of the American Chemical Society · doi:10.1021/ja020675x · Cited by 48 · see citing works

Label-Free Primary Screening and Affinity Ranking of Fragment Libraries Using Parallel Analysis of Protein Panels

Hämäläinen, M., Zhukov, A., Ivarsson, M., Fex, T., Gottfries, J., Karlsson, R., & Björsne, M. (2008) · SLAS DISCOVERY · doi:10.1177/1087057108314651 · Cited by 47 · see citing works

Synthetic Inhibitors of Extended Helix–Protein Interactions Based on a Biphenyl 4,4′‐Dicarboxamide Scaffold

Rodriguez, J. M., Nevola, L., Ross, N. T., Lee, G., & Hamilton, A. D. (2009) · ChemBioChem · doi:10.1002/cbic.200800715 · Cited by 42 · see citing works

The Optical Biosensor Studies on the Role of Hydrophobic Tails of NADPH-Cytochrome P450 Reductase and Cytochromes P450 2B4 and b5 upon Productive Complex Formation within a Monomeric Reconstituted System

Ivanov, Y. D., Kanaeva, I. P., Kuznetsov, V. Y., Lehnerer, M., Schulze, J., Hlavica, P., & Archakov, A. I. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0981 · Cited by 38 · see citing works

Surface Plasmon Resonance Biosensor Based Fragment Screening Using Acetylcholine Binding Protein Identifies Ligand Efficiency Hot Spots (LE Hot Spots) by Deconstruction of Nicotinic Acetylcholine Receptor α7 Ligands

de Kloe, G. E., Retra, K., Geitmann, M., Källblad, P., Nahar, T. T., van Elk, R., Smit, A. B., van Muijlwijk‐Koezen, J. E., Leurs, R., Irth, H., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100834y · Cited by 37 · see citing works

Luminescence Resonance Energy Transfer-Based High-Throughput Screening Assay for Inhibitors of Essential Protein-Protein Interactions in Bacterial RNA Polymerase

Bergendahl, V., Heyduk, T., & Burgess, R. R. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.3.1492-1498.2003 · Cited by 37 · see citing works

SNP Technologies for Drug Discovery: A Current Review

Voisey, J., & Morris, C. P. (2008) · Current Drug Discovery Technologies · doi:10.2174/157016308785739811 · Cited by 36 · see citing works

Electrostatic interactions affecting the active site of class Sigma glutathione S-transferase

Stevens, J. M., Armstrong, R. N., & Dirr, H. W. (2000) · Biochemical Journal · doi:10.1042/bj3470193 · Cited by 36 · see citing works

A Fluorescence Polarization Assay for the Identification of Inhibitors of the p53–DM2 Protein–Protein Interaction

Knight, S. M. G., Umezawa, N., Lee, H., Gellman, S. H., & Kay, B. K. (2002) · Analytical Biochemistry · doi:10.1006/abio.2001.5468 · Cited by 35 · see citing works

Differential scanning fluorimetry as secondary screening platform for small molecule inhibitors of Bcl-X L

Wan, K. F., Wang, S., Brown, C. J., Yu, V. C. K., Entzeroth, M., Lane, D. P., & Lee, M. A. (2009) · Cell Cycle · doi:10.4161/cc.8.23.10114 · Cited by 27 · see citing works

Fragment Screening Purely with Protein Crystallography

Spurlino, J. C. (2011) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-381274-2.00013-3 · Cited by 26 · see citing works

Industrial perspective on X-ray data collection and analysis

Skarzynski, T. J., & Thorpe, J. H. (2005) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444905034281 · Cited by 24 · see citing works

Using Small Molecules and Chemical Genetics To Interrogate Signaling Networks

Carlson, S. M., & White, F. M. (2010) · ACS Chemical Biology · doi:10.1021/cb1002834 · Cited by 23 · see citing works

PROTEIN–PROTEIN INTERACTIONS AS NEW TARGETS FOR DRUG DESIGN: VIRTUAL AND EXPERIMENTAL APPROACHES

Ivanov, A. S., Gnedenko, O. V., Molnar, A. A., Mezentsev, Y. V., Lisitsa, A., & Archakov, A. I. (2007) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720007002825 · Cited by 23 · see citing works

Optical Biosensor Study of Ternary Complex Formation in a Cytochrome P4502B4 System

Ivanov, Y. D., Kanaeva, I. P., & Archakov, A. I. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2973 · Cited by 19 · see citing works

Protein-interaction networks: from experiments to analysis

Schächter, V. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02281-x · Cited by 19 · see citing works

Pyramid: An Integrated Platform for Fragment‐based Drug Discovery

Davies, T. G., van Montfort, R. L. M., Williams, G., & Jhoti, H. (2006) · Methods and principles in medicinal chemistry · doi:10.1002/3527608761.ch10 · Cited by 16 · see citing works

Stability and folding of the protein complexes of barnase

Neira, J. L., Vázquez, E., & Fersht, A. R. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01290.x · Cited by 16 · see citing works

Bioinformatics of Large-Scale Protein Interaction Networks

Schächter, V. (2002) · BioTechniques · doi:10.2144/mar0203 · Cited by 16 · see citing works

Machine Learning in Drug Discovery: A Review

Dara, S., Dhamercherla, S., Jadav, S. S., Babu, C. M., & Ahsan, M. J. (2021) · Artificial Intelligence Review · doi:10.1007/s10462-021-10058-4 · Cited by 843 · see citing works

Modulators of Protein–Protein Interactions

Milroy, L.-G., Grossmann, T. N., Hennig, S., Brunsveld, L., & Ottmann, C. (2014) · Chemical Reviews · doi:10.1021/cr400698c · Cited by 497 · see citing works

Fragment-Based Approaches in Drug Discovery and Chemical Biology

Scott, D. E., Coyne, A. G., Hudson, S. A., & Abell, C. (2012) · Biochemistry · doi:10.1021/bi3005126 · Cited by 460 · see citing works

Targeting protein–protein interactions as an anticancer strategy

Ivanov, A. A., Khuri, F. R., & Fu, H. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.04.007 · Cited by 401 · see citing works

The ID proteins: master regulators of cancer stem cells and tumour aggressiveness

Lasorella, A., Benezra, R., & Iavarone, A. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3638 · Cited by 356 · see citing works

Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development

Sarkar, C., Das, B., Rawat, V. S., Wahlang, J. B., Nongpiur, A., Tiewsoh, I., Lyngdoh, N. M., Das, D., Bidarolli, M., & Sony, H. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032026 · Cited by 347 · see citing works

Oncogenic protein interfaces: small molecules, big challenges

Nero, T. L., Morton, C. J., Holien, J. K., Wielens, J., & Parker, M. W. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3690 · Cited by 312 · see citing works

Artificial intelligence in drug design

Zhong, F., Xing, J., Li, X., Liu, X., Fu, Z., Xiong, Z., Lu, D., Wu, X., Zhao, J., Tan, X., et al. (2018) · Science China Life Sciences · doi:10.1007/s11427-018-9342-2 · Cited by 288 · see citing works

Features of protein–protein interactions that translate into potent inhibitors: topology, surface area and affinity

Smith, M. C. P., & Gestwicki, J. E. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2012.10 · Cited by 285 · see citing works

New insights into protein–protein interaction modulators in drug discovery and therapeutic advance

Nada, H., Choi, Y., Kim, S.-D., Jeong, K. S., Meanwell, N. A., & Lee, K. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02036-3 · Cited by 233 · see citing works

Druggable protein–protein interactions – from hot spots to hot segments

London, N., Raveh, B., & Schueler‐Furman, O. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.10.011 · Cited by 224 · see citing works

Long-term delivery of protein therapeutics

Vaishya, R. D., Khurana, V., Patel, S. P., & Mitra, A. K. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.961420 · Cited by 195 · see citing works

Systematic Targeting of Protein–Protein Interactions

Modell, A. E., Blosser, S. L., & Arora, P. S. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.05.008 · Cited by 184 · see citing works

Structural biology and drug discovery for protein–protein interactions

Jubb, H. C., Higueruelo, A. P., Winter, A., & Blundell, T. L. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.006 · Cited by 182 · see citing works

State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors

Sheng, C., Dong, G., Miao, Z., Zhang, W., & Wang, W. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00252d · Cited by 165 · see citing works

Overcoming Chemical, Biological, and Computational Challenges in the Development of Inhibitors Targeting Protein-Protein Interactions

Laraia, L., McKenzie, G. J., Spring, D. R., Venkitaraman, A. R., & Huggins, D. J. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.04.019 · Cited by 152 · see citing works

Hypoxia Inducible Factor Pathway Inhibitors as Anticancer Therapeutics

Burroughs, S. K., Kaluz, S., Wang, D., Wang, K., Van Meir, E. G., & Wang, B. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.17 · Cited by 140 · see citing works

Microseed matrix screening for optimization in protein crystallization: what have we learned?

D'Arcy, A., Bergfors, T., Cowan‐Jacob, S. W., & Marsh, M. (2014) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x14015507 · Cited by 133 · see citing works

Protein–protein interactions as druggable targets: recent technological advances

Higueruelo, A. P., Jubb, H. C., & Blundell, T. L. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.05.009 · Cited by 126 · see citing works

Targeting protein–protein interactions, a wide open field for drug design

Bakail, M., & Ochsenbein, F. (2016) · Comptes Rendus. Chimie · doi:10.1016/j.crci.2015.12.004 · Cited by 117 · see citing works

Evolutions in fragment-based drug design: the deconstruction–reconstruction approach

Chen, H., Zhou, X., Wang, A., Zheng, Y., Gao, Y., & Zhou, J. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.09.015 · Cited by 115 · see citing works

Evolution of In Silico Strategies for Protein-Protein Interaction Drug Discovery

Macalino, S. J. Y., Basith, S., Clavio, N. A. B., Chang, H., Kang, S., & Choi, S. (2018) · Molecules · doi:10.3390/molecules23081963 · Cited by 113 · see citing works

NMR-Based Approaches for the Identification and Optimization of Inhibitors of Protein–Protein Interactions

Barile, E., & Pellecchia, M. (2014) · Chemical Reviews · doi:10.1021/cr500043b · Cited by 109 · see citing works

Ras inhibition via direct Ras binding—is there a path forward?

Wang, W., Fang, G., & Rudolph, J. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.07.082 · Cited by 104 · see citing works

The design and development of covalent protein-protein interaction inhibitors for cancer treatment

Cheng, S.-S., Yang, G.-J., Wang, W., Leung, C.-H., & Ma, D.-L. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00850-0 · Cited by 98 · see citing works

Antibody-enabled small-molecule drug discovery

Lawson, A. D. G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3756 · Cited by 80 · see citing works

Fragment-Based Drug Discovery and X-Ray Crystallography

Davies, T. G., & Hyvönen, M. (2012) · Topics in current chemistry · doi:10.1007/978-3-642-27540-1 · Cited by 77 · see citing works

High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists

Wu, B., Barile, E., De, S. K., Wei, J., Purves, A., & Pellecchia, M. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150519102459 · Cited by 61 · see citing works

An overview of recent molecular dynamics applications as medicinal chemistry tools for the undruggable site challenge

Perricone, U., Gulotta, M. R., Lombino, J., Parrino, B., Cascioferro, S., Diana, P., Cirrincione, G., & Padova, A. (2018) · MedChemComm · doi:10.1039/c8md00166a · Cited by 52 · see citing works

Developments in SPR Fragment Screening

Chavanieu, A., & Pugnière, M. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1160888 · Cited by 51 · see citing works

2P2I HUNTER : a tool for filtering orthosteric protein–protein interaction modulators via a dedicated support vector machine

Hamon, V., Bourgeas, R., Ducrot, P., Théret, I., Xuereb, L., Basse, M. J., Brunel, J. M., Combes, S., Morelli, X., & Roche, P. (2013) · Journal of The Royal Society Interface · doi:10.1098/rsif.2013.0860 · Cited by 46 · see citing works

From Concepts to Inhibitors: A Blueprint for Targeting Protein–Protein Interactions

Hong, S. H., Nguyễn, T. T., Ongkingco, J. F., Nazzaro, A., & Arora, P. S. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00046 · Cited by 44 · see citing works

Molecular recognition in the human immunodeficiency virus capsid and antiviral design

Bocanegra, R., Rodríguez‐Huete, A., Fuertes, M. A., del Álamo, M., & Mateu, M. G. (2012) · Virus Research · doi:10.1016/j.virusres.2012.06.016 · Cited by 43 · see citing works

Stapled BH3 Peptides against MCL-1: Mechanism and Design Using Atomistic Simulations

Joseph, T. L., Lane, D. P., & Verma, C. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043985 · Cited by 43 · see citing works

Computational analysis of EBNA1 “druggability” suggests novel insights for Epstein-Barr virus inhibitor design

Gianti, E., Messick, T. E., Lieberman, P. M., & Zauhar, R. J. (2016) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-016-9899-y · Cited by 43 · see citing works

Novel, Self-Assembling Dimeric Inhibitors of Human β Tryptase

Giardina, S. F., Werner, D. S., Pingle, M., Feinberg, P. B., Foreman, K. W., Bergstrom, D. E., Arnold, L. D., & Barany, F. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01689 · Cited by 43 · see citing works

Overview of Probing Protein‐Ligand Interactions Using NMR

Aguirre, C., Cala, O., & Krimm, I. (2015) · Current Protocols in Protein Science · doi:10.1002/0471140864.ps1718s81 · Cited by 42 · see citing works

Developing Small‐Molecule Inhibitors of HECT‐Type Ubiquitin Ligases for Therapeutic Applications: Challenges and Opportunities

Chen, D., Gehringer, M., & Lorenz, S. (2018) · ChemBioChem · doi:10.1002/cbic.201800321 · Cited by 40 · see citing works

Structural Properties of Non-Traditional Drug Targets Present New Challenges for Virtual Screening

Gowthaman, R., Deeds, E. J., & Karanicolas, J. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci4002316 · Cited by 38 · see citing works

Inhibition of Viral Membrane Fusion by Peptides and Approaches to Peptide Design

Düzgüneş, N., Fernández‐Fuentes, N., & Konopka, K. (2021) · Pathogens · doi:10.3390/pathogens10121599 · Cited by 38 · see citing works

Progress in discovery of small-molecule modulators of protein–protein interactions via fragment screening

Magee, T. V. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.04.089 · Cited by 34 · see citing works

Targeting the cryptic sites: NMR-based strategy to improve protein druggability by controlling the conformational equilibrium

Mizukoshi, Y., Takeuchi, K., Tokunaga, Y., Matsuo, H., Imai, M., Fujisaki, M., Kamoshida, H., Takizawa, T., Hanzawa, H., & Shimada, I. (2020) · Science Advances · doi:10.1126/sciadv.abd0480 · Cited by 31 · see citing works

Protein-Protein Interactions and Aggregation Inhibitors in Alzheimer’s Disease

Ganeshpurkar, A., Swetha, R., Kumar, D., Gangaram, G. P., Singh, R., Gutti, G., Jana, S., Kumar, D., Kumar, A., & Singh, S. K. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190304153353 · Cited by 30 · see citing works

Mapping oncogenic protein interactions for precision medicine

Tabar, M. S., Francis, H., Yeo, D., Bailey, C. G., & Rasko, J. E. J. (2022) · International Journal of Cancer · doi:10.1002/ijc.33954 · Cited by 30 · see citing works

Protein-protein interaction inhibitors: advances in anticancer drug design

Ferreira, L. L. G., Oliva, G., & Andricopulo, A. D. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1223038 · Cited by 29 · see citing works

19F-NMR in Target-based Drug Discovery

Kang, C. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190610160534 · Cited by 27 · see citing works

Remote Control by Inter-Enzyme Allostery: A Novel Paradigm for Regulation of the Shikimate Pathway

Munack, S., Würth-Roderer, K., Ökvist, M., Fahrig‐Kamarauskaitė, J., Sasso, S., van Eerde, A., Kast, P., & Krengel, U. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.01.001 · Cited by 27 · see citing works

Applications of Solution NMR in Drug Discovery

Li, S., & Zhang, N. (2021) · Molecules · doi:10.3390/molecules26030576 · Cited by 26 · see citing works

Computer-aided design and discovery of protein–protein interaction inhibitors as agents for anti-HIV therapy

Veselovsky, A. V., Zharkova, M. S., Poroikov, V., & Nicklaus, M. C. (2014) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2014.898689 · Cited by 25 · see citing works

Direct monitoring of protein–protein inhibition using nano electrospray ionization mass spectrometry

Cubrilovic, D., Barylyuk, K. V., Hofmann, D., Walczak, M., Gräber, M., Berg, T., Wider, G., & Zenobi, R. (2014) · Chemical Science · doi:10.1039/c3sc53360c · Cited by 25 · see citing works

Pharmacological modulation of oncogenic Ras by natural products and their derivatives: Renewed hope in the discovery of novel anti-Ras drugs

Quah, S. Y., Tan, M. S., Teh, Y. H., & Stanslas, J. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.03.010 · Cited by 25 · see citing works

Fragment-Based Lead Discovery

Davis, B. J., & Roughley, S. D. (2017) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2017.07.002 · Cited by 25 · see citing works

Set-up and screening of a fragment library targeting the 14-3-3 protein interface

Valenti, D., Neves, J. F., Cantrelle, F., Hristeva, S., Santo, D. L., Obšil, T., Hanoulle, X., Levy, L. M., Tzalis, D., Landrieu, I., et al. (2019) · MedChemComm · doi:10.1039/c9md00215d · Cited by 23 · see citing works

Inhibition of herpesvirus and influenza virus replication by blocking polymerase subunit interactions

Palù, G., & Loregian, A. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.05.014 · Cited by 21 · see citing works

Using SHAPE-MaP to probe small molecule-RNA interactions

Martin, S. E., Blankenship, C., Rausch, J. W., & Sztuba-Solińska, J. (2019) · Methods · doi:10.1016/j.ymeth.2019.04.009 · Cited by 21 · see citing works

Fragment library screening identifies hits that bind to the non-catalytic surface of Pseudomonas aeruginosa DsbA1

Mohanty, B., Rimmer, K. A., McMahon, R. M., Headey, S. J., Vazirani, M., Shouldice, S. R., Coincon, M., Tay, S. V., Morton, C. J., Simpson, J. S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173436 · Cited by 21 · see citing works

Fragment-Based Identification of a Locus in the Sec7 Domain of Arno for the Design of Protein–Protein Interaction Inhibitors

Rouhana, J., Hoh, F., Estaran, S., Henriquet, C., Boublik, Y., Kerkour, A., Trouillard, R., Martínez, J., Pugnière, M., Padilla, A., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4009357 · Cited by 19 · see citing works

Small-Molecule Inhibitors of Protein–Protein Interactions

Liu, Z., Chen, H., Wold, E. A., & Zhou, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12326-1 · Cited by 19 · see citing works

The power of the yeast two-hybrid system in the identification of novel drug targets: building and modulating PPP1 interactomes

Silva, J. V., Freitas, M. J., Felgueiras, J., & Fardilha, M. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2015.1024226 · Cited by 18 · see citing works

Discovery of Novel Drugs for Promising Targets

Martell, R. E., Brooks, D. G., Wang, Y., & Wilcoxen, K. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.08.005 · Cited by 17 · see citing works

Selected Approaches to Disrupting Protein–Protein Interactions within the MAPK/RAS Pathway

Harwood, S. J., Smith, C. R., Lawson, J. D., & Ketcham, J. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087373 · Cited by 16 · see citing works

Computational probing protein–protein interactions targeting small molecules

Wang, Y., Chen, S., Deng, N.-Y., & Wang, Y. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv528 · Cited by 15 · see citing works

Functional Mapping of Protein-Protein Interactions in an Enzyme Complex by Directed Evolution

Würth-Roderer, K., Neuenschwander, M., Codoni, G., Sasso, S., Gamper, M., & Kast, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116234 · Cited by 14 · see citing works

Pharmacological targeting of α‐synuclein and TPPP /p25 in Parkinson's disease: challenges and opportunities in a Nutshell

Oláh, J., & Ovádi, J. (2019) · FEBS Letters · doi:10.1002/1873-3468.13464 · Cited by 14 · see citing works

Protein-Protein Interactions: Structures and Druggability

Ascher, D. B., Jubb, H. C., Pires, D. E. V., Ochi, T., Higueruelo, A. P., & Blundell, T. L. (2015) · NATO science for peace and security series. A, Chemistry and biology · doi:10.1007/978-94-017-9719-1_12 · Cited by 13 · see citing works

Fragment‐Based Drug Discovery

Renaud, J., Neumann, T., & Hijfte, L. V. (2015) · Wiley eBooks · doi:10.1002/9781118771723.ch8 · Cited by 13 · see citing works

Selective Targeting of the TPX2 Site of Importin‐α Using Fragment‐Based Ligand Design

Holvey, R. S., Valkov, E., Neal, D. E., Stewart, M., & Abell, C. (2015) · ChemMedChem · doi:10.1002/cmdc.201500014 · Cited by 11 · see citing works

Combined Action of Human Commensal Bacteria and Amorphous Silica Nanoparticles on the Viability and Immune Responses of Dendritic Cells

Malachin, G., Lubian, E., Mancin, F., Papini, E., & Tavano, R. (2017) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00178-17 · Cited by 11 · see citing works

Targeting HINT1 to improve synaptic plasticity: toward loganin as a new antidepressant strategy

Xia, C., Zuo, G., Wang, M., Wang, Y., Guo, Y., Han, Y., Xiang, H., Cheng, Y., Xu, J., He, J., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02959-5 · Cited by 10 · see citing works

Fast fragment and compound screening pipeline at the Swiss Light Source

Stegmann, D. P., Steuber, J., Fritz, G., Wojdyla, J. A., & Sharpe, M. E. (2023) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2023.08.005 · Cited by 10 · see citing works

Increased slow dynamics defines ligandability of BTB domains

Kharchenko, V., Linhares, B. M., Borregard, M., Czaban, I., Grembecka, J. E., Jaremko, M., Cierpicki, T., & Jaremko, Ł. (2022) · Nature Communications · doi:10.1038/s41467-022-34599-6 · Cited by 8 · see citing works

Exploring protein-protein interactions for the development of new analgesics

do Nascimento, A. M., Marques, R. B., Roldão, A. P., Rodrigues, A. M. G. D., Eslava, R. M., Dale, C. S., Reis, E. M. R., & Schechtman, D. (2024) · Science Signaling · doi:10.1126/scisignal.adn4694 · Cited by 7 · see citing works

Target-Directed Self-Assembly of Homodimeric Drugs Against β-Tryptase

Giardina, S. F., Werner, D. S., Pingle, M., Foreman, K. W., Bergstrom, D. E., Arnold, L. D., & Barany, F. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00204 · Cited by 7 · see citing works

Peptides: minimal drug surrogates to interrogate and interfere with protein function

Cruz-Migoni, A., Fuentes-Fernandez, N., & Rabbitts, T. H. (2013) · MedChemComm · doi:10.1039/c3md00142c · Cited by 6 · see citing works

In silico peptide-directed ligand design complements experimental peptide-directed binding for protein–protein interaction modulator discovery

Howell, L. A., & Beekman, A. M. (2020) · RSC Chemical Biology · doi:10.1039/d0cb00148a · Cited by 6 · see citing works

Evaluation of Computationally Designed Peptides against TWEAK, a Cytokine of the Tumour Necrosis Factor Ligand Family

Badia-Villanueva, M., Defaus, S., Foj, R., Andreu, D., Oliva, B., Sierra, À., & Fernández‐Fuentes, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031066 · Cited by 6 · see citing works

Viral hijacking mechanism in humans through protein–protein interactions

Selvaraj, C., Shri, G. R., Vijayakumar, R., Alothaim, A. S., Ramya, S., & Singh, S. K. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2022.05.001 · Cited by 6 · see citing works

The role of hydration effects in 5-fluorouridine binding to SOD1: insight from a new 3D-RISM-KH based protocol for including structural water in docking simulations

Hinge, V. K., Blinov, N., Roy, D., Wishart, D. S., & Kovalenko, A. (2019) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-019-00239-3 · Cited by 5 · see citing works

Optimization of a Bioluminescence Resonance Energy Transfer-Based Assay for Screening of Trypanosoma cruzi Protein/Protein Interaction Inhibitors

Mild, J. G., Fernández, L. R., Gayet, O., Iovanna, J., Dusetti, N., & Edreira, M. M. (2018) · Molecular Biotechnology · doi:10.1007/s12033-018-0078-3 · Cited by 5 · see citing works

Molecular Docking-assisted Protein Chip Screening of Inhibitors for Bcl-2 Family Protein-protein Interaction to Discover Anticancer Agents by Fragment-based Approach

Yoou, M., Cho, S., & Choi, Y. (2019) · BioChip Journal · doi:10.1007/s13206-019-3306-4 · Cited by 5 · see citing works

Molecular Docking Study of Flavonoids to Block the Aryl Hydrocarbon Receptor

García, O. G. C., Winter, H. L. D., Cos, P., Matos, M. J., Uriarte, E., Maury, G. L., Waele, J. D., Santiago, G. C., & Molina, E. (2021) · International Electronic Conference on Synthetic Organic Chemistry (ECSOC) · doi:10.3390/ecsoc-25-11766 · Cited by 5 · see citing works

Modulation of interaction of mutant TP53 and wild type BRCA1 by alkaloids: a computational approach towards targeting protein-protein interaction as a futuristic therapeutic intervention strategy for breast cancer impediment

Tiwari, S., Awasthi, M., Singh, S., Pandey, V. P., & Dwivedi, U. N. (2017) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2017.1388286 · Cited by 5 · see citing works

Applications of Ligand and Protein‐Observed NMR in Ligand Discovery

Krimm, I. (2017) · Wiley eBooks · doi:10.1002/9781119099512.ch10 · Cited by 5 · see citing works

Mapping of endoglucanases displayed on yeast cell surface using atomic force microscopy

Takenaka, M., Kobayashi, T., Inokuma, K., Hasunuma, T., Maruyama, T., Ogino, C., & Kondo, A. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.12.014 · Cited by 4 · see citing works

Discovery of Inhibitors of Protein–Protein Interactions Using Fragment‐Based Methods

Wang, F., & Fesik, S. W. (2016) · Methods and principles in medicinal chemistry · doi:10.1002/9783527683604.ch16 · Cited by 4 · see citing works

Prospects on Strategies for Therapeutically Targeting Oncogenic Regulatory Factors by Small-Molecule Agents

Chou, C.-C., Salunke, S. B., Kulp, S. K., & Chen, C. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24704 · Cited by 3 · see citing works

Gγ recruitment systems specifically select PPI and affinity-enhanced candidate proteins that interact with membrane protein targets

Kaishima, M., Ishii, J., 福田, 展., & Kondo, A. (2015) · Scientific Reports · doi:10.1038/srep16723 · Cited by 3 · see citing works

A Review on Protein-Protein Interaction Network Databases

Pedamallu, C. S., & Özdamar, L. (2014) · Springer proceedings in mathematics & statistics · doi:10.1007/978-3-319-04849-9_30 · Cited by 3 · see citing works

Targeted Inhibitor Design: Lessons from Small Molecule Drug Design, Directed Evolution, and Vaccine Research

Park, S., Mann, J. K., & Li, N. (2013) · Cited by 2 · see citing works

Other Nonbiological Approaches to Targeted Cancer Chemotherapy

Avendaño, C., & Menéndez, J. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-62649-3.00011-9 · Cited by 2 · see citing works

In Silico Identification of Potential Antagonists Targeting the HPV16 E2-E1 Interaction: A Step Toward Novel Therapeutics for Cervical Cancer

Mireles, J. A. G., Loera‐Castañeda, V., Ávila, J. C. G., Fierro, I. V., Muñoz, C. M., Gándara, H. P., Castañeda, G. A. L., Romero, L. P., & Almanza-Reyes, H. E. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47040288 · Cited by 1 · see citing works

Mutational landscapes of HNF MODY gene products display a wide distribution with functional implications

Chi, Y., & Urrutia, R. A. (2025) · Endocrine Connections · doi:10.1530/ec-25-0345 · Cited by 1 · see citing works

Overview of Protein-Protein Interactions and Small-Molecule Inhibitors Under Clinical Development

Dong, G., & Sheng, C. (2018) · Springer eBooks · doi:10.1007/978-981-13-0773-7_1 · Cited by 1 · see citing works

High Throughput Screening Methods for PPI Inhibitor Discovery

Doyle, S. P., Mo, X., Qian, K., Cicka, D., Niu, Q., & Fu, H. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016544-00049 · Cited by 1 · see citing works

An Experimental Evaluation of Summarisation-Based Frequent Subgraph Mining for Subgraph Searching

Wangmo, C., & Wiese, L. (2024) · SN Computer Science · doi:10.1007/s42979-024-03006-w · Cited by 1 · see citing works

A Structural View on Druggability

Egner, U., & Hillig, R. C. (2020) · Wiley eBooks · doi:10.1002/9781118681121.ch2 · Cited by 1 · see citing works

machine interaction modulators via a dedicated support vector protein - : a tool for filtering orthosteric protein HUNTER 2P2I

Brunel, J. M., Combes, S., Morelli, X., Roche, P., Hamon, V., Théret, I., & Xuereb, L. (2013)

Faculty Opinions recommendation of Targeting the cryptic sites: NMR-based strategy to improve protein druggability by controlling the conformational equilibrium.

Jahnke, W. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738775439.793580691

Structure- and Dynamics-guided Drug Development Using NMR and its Application to Diverse Pharmaceutical Modalities

Takeuchi, K. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839165702-00411

General aspects of cancer therapy

Avendaño, C., & Menéndez, J. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818549-0.00002-9

Fragment-based drug discovery and protein–protein interactions

Turnbull, A. P., Boyd, S., & Walse, B. (2014) · Research and Reports in Biochemistry · doi:10.2147/rrbc.s28428 · Cited by 21 · see citing works

Protein–protein interactions as druggable targets: recent technological advances

Higueruelo, A. P., Jubb, H. C., & Blundell, T. L. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.05.009 · Cited by 126 · see citing works

Future Frontiers in Small Molecule Inhibitors of Protein-Protein Interactions

Ma, D., Leung, C., & Chan, D. S. (2013) · International Journal of Bioorganic Chemistry & Molecular Biology · doi:10.19070/2332-2756-130002e

Biophysical and computational fragment-based approaches to targeting protein–protein interactions: applications in structure-guided drug discovery

Winter, A., Higueruelo, A. P., Marsh, M., Sigurdardottir, A., Pitt, W. R., & Blundell, T. L. (2012) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583512000108 · Cited by 115 · see citing works

Systematic Targeting of Protein–Protein Interactions

Modell, A. E., Blosser, S. L., & Arora, P. S. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.05.008 · Cited by 184 · see citing works